Skip to content

The comparison of novafen and ibuprofen in pain relief caused by orthodontic separators

The comparison of novafen and ibuprofen in pain relief caused by orthodontic separators: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251112067976N1
Enrollment
66
Registered
2025-12-09
Start date
2025-11-16
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain resulting from orthodontic separators.

Interventions

Intervention 1: Intervention group: ibuprofen. Intervention 2: Intervention group: novafen. Intervention 3: Control group: no drug will be given.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 41 Years

Inclusion criteria

Inclusion criteria: Individuals scheduled for orthodontic separators placement. Patients with no contraindications to ibuprofen, novafen The appreciate to participate and provide informed consent Patients without underlying disease Patients who do not take medication

Exclusion criteria

Exclusion criteria: History of allergic reactions or intolerance to ibuprofen, acetaminophen, or caffeine. Contraindications to NSAIDs or acetaminophen (e.g., gastrointestinal bleeding, liver disease) Pregnant or breastfeeding individuals.

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of novafen and ibuprofen in pain relief caused by orthodontic separators. Timepoint: Participants will complete a three-question pain assessment survey at predetermined intervals (?h,?h after orthodontic separator replacement,bedtime on the day of replacement, next day morning,and the ?nd day, ?rd day, ?th day morning after separator replacement), tracking pain intensity and relief. Method of measurement: questionnaire (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKawthar Halawi

Tehran University of Medical Sciences

Kawthar.halawikh@gmail.com+98 21 8896 5097

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026